SEC Form 4 · accession 0001477932-17-006280
Innovation Pharmaceuticals Inc. · IPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Peter Bertolino
Officer — President and CMO
Period of report
Dec 22, 2017
Accepted (ET)
Dec 27, 2017 · 3:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355250
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dec 22, 2017 | F | 238,048 | $0.70 | D | 1,633,206 | D |
Table II — derivative securities
No Table II lines on this filing.